2017: The Effectiveness of tDCS/tACS/tRNS and pEMF Stimulation on EEG Neurotherapy Performance (Plenary Session)

In this session a discussion regarding neurostimulation technology will be conducted. The speaker will show how neurostimulation that is synchronized with EEG neurotherapy can enhance and facilitate regulation of the brain based on QEEG assessment and behavioral observational data. The limitations of EEG neurofeedback prevent adequate treatment outcomes on “tough cases” (such as autism) and decrease the credibility of the field in general when no treatment effects are observed. One of the main reasons for poor neurofeedback outcomes is associated with deregulation of the human connectome, or rich club. The human connectome has been strongly associated with the default mode network, and deregulation of this network can lead to poor communication between important network hubs that are responsible for regulating the brain. The speaker will discuss the current MRI BOLD research associated with physiological responses to pEMF, tDCS/tACS/tRNS stimulation. In 2016 multiple studies were published that show how stimulation technology triggers calcium ion activation in the glia which gives rise to global neuroplasticity responses. This new data supports the use of neurostimulation methods as they can help to facilitate changes in absolute power, coherence and phase towards the norm. The speaker will show and discuss QEEG and outcome data associated with clinical cases diagnosed with Autism, ADHD, Depression, Anxiety and Parkinson’s disease. Each of the cases discussed with include a summary of patient information, diagnosis, history and treatment plan. Each case will be presented with pre and post treatment EEG data. Behavioral changes will be discussed showing the effectiveness of EEG neurofeedback.

Category:

$20.00

In this session a discussion regarding neurostimulation technology will be conducted. The speaker will show how neurostimulation that is synchronized with EEG neurotherapy can enhance and facilitate regulation of the brain based on QEEG assessment and behavioral observational data. The limitations of EEG neurofeedback prevent adequate treatment outcomes on “tough cases” (such as autism) and decrease the credibility of the field in general when no treatment effects are observed. One of the main reasons for poor neurofeedback outcomes is associated with deregulation of the human connectome, or rich club. The human connectome has been strongly associated with the default mode network, and deregulation of this network can lead to poor communication between important network hubs that are responsible for regulating the brain. The speaker will discuss the current MRI BOLD research associated with physiological responses to pEMF, tDCS/tACS/tRNS stimulation. In 2016 multiple studies were published that show how stimulation technology triggers calcium ion activation in the glia which gives rise to global neuroplasticity responses. This new data supports the use of neurostimulation methods as they can help to facilitate changes in absolute power, coherence and phase towards the norm. The speaker will show and discuss QEEG and outcome data associated with clinical cases diagnosed with Autism, ADHD, Depression, Anxiety and Parkinson’s disease. Each of the cases discussed with include a summary of patient information, diagnosis, history and treatment plan. Each case will be presented with pre and post treatment EEG data. Behavioral changes will be discussed showing the effectiveness of EEG neurofeedback.

We’ve Moved…

To accommodate the organization’s growing needs, we have decided to move our office to a new location.

2146 Roswell Road

Suite 108, PMB 736

Marietta, GA 30062

USA

2017: The Effectiveness of tDCS/tACS/tRNS and pEMF Stimulation on EEG Neurotherapy Performance (Plenary Session)
Scroll to Top

Are you having problems clicking next on the membership form?

You must have 3rd party cookies set to “Always Accept.”

Internet Explorer 7 on Windows

  • Click the “Tools” menu
  • Click “Internet Options”
  • Select the “Privacy” tab
  • Option 1: To enable third-party cookies for all sites
  • Click “Advanced”
  • Select “Override automatic cookie handling”
  • Select the “Accept” button under “Third-party Cookies” and click “OK”

Firefox 3 on Windows

  • Click the “Tools” menu
  • Click “Options…”
  • Select the “Privacy” menu
  • Make sure “Keep until” is set to “they expire”
  • Option 1: To enable third party cookies for ALL sites: Make sure “Accept third-party cookies” is checked

Safari on Apple OS X:

  • Click the “Safari” menu
  • Click “Preferences…”
  • Click the “Security” menu
  • For “Cookies and website data” unselect “Block all cookies”
  • For “Website tracking”, unselect “Prevent cross-site tracking”
Safari enable cookies for membership purchase.

Firefox 3 on Apple OS X:

  • Click the “Firefox” menu
  • Click Preferences…
  • Click the Privacy menu
  • Make sure “Keep until” is set to “they expire”
  • Option 1: To enable third-party cookies for ALL sites: Make sure “Accept third-party cookies” is checked

Google Chrome on Windows

  • Select the Wrench (spanner) icon at the top right
  • Select “Options”
  • Select the “Under the Hood” tab
  • Select “Allow all cookies” under “Cookie Settings” and click “Close”

Internet Explorer 6 on Windows

  • Click the “Tools” menu
  • Click “Internet Options”
  • Select the “Privacy” tab
  • Move the settings slider to “Low” or “Accept all cookies”
  • Click “OK”

Opera 9 on Windows

  • Click the “Tools” menu
  • Click “Preferences…”
  • Click the “Advanced” tab
  • Select “Cookies” on the left list
  • Make sure “Accept cookies” is selected and uncheck “Delete new cookies when exiting Opera”
  • Click “OK”